True or false—and if anyone knows, she should, say cynics—this is news to those who have been protesting at public-sector wage cuts of up to 25%, and months of delayinpayment.
For more than a decade, the Commission has been toiling unsuccessfully in federal court, and in Congress, to prohibit so-called pay-for-delay or reverse payment drug patent settlements.